Chip Paul is a forensic researcher of the endocannabinoid system and co-founder of GnuPharma Corp. which holds the first patent ever issued for predictable manipulation of the endocannabinoid system using non-cannabis plants. GnuPharma also holds patents pending on its model of human function, which is a research-backed model capable of viewing disease states in a different manner. GnuPharma's model assumes the human condition is influenced by diet and by the environment. Using this knowledge it is possible to influence not only disease but also genetics with diet and supplementation.